SCHEMBL10147778

SCHEMBL10147778

N/C(=N\O)c1c(F)cc(Cl)cc1Br

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.34
IDO1 P14902 1/20 0.33
DGAT1 O75907 1/20 0.33
MCL1 Q07820 1/20 0.33
SPR P35270 1/20 0.31
NPC1 O15118 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
GRM2 Q14416 1/20 0.31
HTR3E A5X5Y0 1/20 0.31
HTR3B O95264 1/20 0.31
HTR3A P46098 1/20 0.31
HTR3D Q70Z44 1/20 0.31
HTR3C Q8WXA8 1/20 0.31
KDM1A O60341 1/20 0.30
MAP2 P11137 1/20 0.30
ERN1 O75460 1/20 0.30
SLC9A1 P19634 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31140501 0.81 DGAT1 (0.39) PLAUIDO1DGAT1MCL1SPR
SCHEMBL31140494 0.76 MCL1 (0.42) MCL1SPRNPC1HPGDRAB9A
SCHEMBL27220403 0.70 CA1 (0.32) DGAT1KDM1A
SCHEMBL20267886 0.70 HTR3E (0.36) IDO1SMN1; SMN2GRM2HTR3EHTR3B
SCHEMBL8416556 0.70 ITGB3 (0.34) IDO1KDM1A
SCHEMBL25280044 0.70 LMNA (0.40) NPC1HPGDRAB9ASMN1; SMN2
SCHEMBL3024877 0.70 GRM2 (0.42) IDO1DGAT1SPRGRM2MAP2
SCHEMBL4254508 0.70 KDM1A (0.36) KDM1AERN1
SCHEMBL11880011 0.69 PLAU (0.46) PLAUIDO1NPC1RAB9AHTR3E
SCHEMBL9947816 0.69 IDO1 (0.32) IDO1NPC1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150065516-A1 NEW BIARYL AMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. 2015-03-05 US disclosed
US-20150065516-A1 NEW BIARYL AMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. 2015-03-05 US disclosed
US-8912221-B2 Biaryl amide derivatives HOFFMANN-LA ROCHE INC. (US) 2014-12-16 US disclosed
US-8912221-B2 Biaryl amide derivatives HOFFMANN-LA ROCHE INC. (US) 2014-12-16 US disclosed
EP-2668155-B1 NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-11-26 EP disclosed
US-20130018055-A1 NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2013-01-17 US disclosed
US-20130018055-A1 NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2013-01-17 US disclosed
US-20120165338-A1 NEW BIARYL AMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. 2012-06-28 US disclosed
US-20120165338-A1 NEW BIARYL AMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150065516-A1 NEW BIARYL AMIDE DERIVATIVES BICRA, HDAC10, BRD7 PLAU 4838/4885IDO1 1099/4885DGAT1 3375/4885
US-20130018055-A1 NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES CYP1A1, AHR, CYP1B1 PLAU 4869/4885IDO1 1555/4885DGAT1 3997/4885
US-20120165338-A1 NEW BIARYL AMIDE DERIVATIVES BICRA, HDAC10, BRD7 PLAU 4838/4885IDO1 1099/4885DGAT1 3375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.